Inactive Instrument

ALZA Corporation Stock

AZA

US0226151084

Biotechnology & Medical Research

End-of-day quote NYSE
-	-

Managers and Directors: ALZA Corporation

Manager	Title	Age	Since
Blake C. Ludwig CEO	Chief Executive Officer	-	-

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+0.02%	-2.90%	+1.26%	+18.93%	48.42B
REVOLUTION MEDICINES, INC.	+0.85%	-0.70%	+460.88%	+581.30%	43.66B
BEONE MEDICINES AG	-2.40%	-0.23%	+8.13%	+80.67%	39.51B
IQVIA HOLDINGS INC.	-2.01%	-0.85%	+23.85%	+9.97%	38.95B
CELLTRION, INC.	-0.50%	+0.85%	+20.60%	+58.18%	32.61B
ASCENDIS PHARMA A/S	+0.38%	-3.23%	-	-	16.32B
MEDPACE HOLDINGS, INC.	-0.59%	-2.06%	+26.35%	+126.36%	16.15B
EUROFINS SCIENTIFIC SE	-1.76%	-1.20%	+2.76%	+26.28%	14.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.43%	+4.70%	+78.74%	+38.66%	13.37B
Average	-0.71%	-0.35%	+77.82%	+117.54%	29.24B
Weighted average by Cap.	-0.70%	-0.62%	+95.71%	+140.59%

See all sector performances

Provides drug delivery solutions with an array of technology platforms, including oral, transdermal, implantable and liposomal technologies. The Company partners with pharmaceutical and biotechnology companies to develop and manufacture pharmaceutical products that enhance healthcare for patients worldwide.

Employees

Sector

Biotechnology & Medical Research

More about the company